Glucose Counterregulation and Waning of Insulin in the Somogyi Phenomenon (Posthypoglycemic Hyperglycemia)
- 8 November 1984
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 311 (19) , 1214-1219
- https://doi.org/10.1056/nejm198411083111904
Abstract
To determine the roles of glucose counterregulation and the waning of insulin action in the development of posthypoglycemic hyperglycemia (the Somogyi phenomenon), we studied changes in plasma glucose and glucose turnover in five patients with insulin-dependent diabetes mellitus (IDDM) after subcutaneous injection of insulin under conditions in which hypoglycemic glucose counterregulation and the waning of insulin action were allowed to occur or were prevented. In control experiments, in which both glucose counterregulation and insulin waning were allowed to occur, plasma glucose levels decreased from 94±3 to 47±7 mg per deciliter and then increased to 289±20 mg per deciliter at 12 hours because of a marked increase in glucose production. When the waning of insulin action was prevented by insulin infusion, glucose production increased less (P<0.01), but marked rebound hyperglycemia still occurred (188±26 mg per deciliter at 12 hours). When both insulin waning and glucose counterregulation were prevented by infusion of both glucose and insulin, glucose production did not increase, and rebound hyperglycemia did not occur. We conclude that hypoglycemia can cause rebound hyperglycemia in the absence of insulin waning in patients with IDDM, and that this results primarily from an excessive increase in glucose production due to activation of glucose counterregulatory systems. (N Engl J Med 1984; 311:1214–9.)This publication has 31 references indexed in Scilit:
- Abnormal Glucose Counterregulation after Subcutaneous Insulin in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1984
- The Somogyi PhenomenonArchives of internal medicine (1960), 1984
- Excessive Insulin Therapy: Biochemical Effects and Clinical RepercussionsAnnals of Internal Medicine, 1983
- Role of Epinephrine-mediated β-Adrenergic Mechanisms in Hypoglycemic Glucose Counterregulation and Posthypoglycemic Hyperglycemia in Insulin-dependent Diabetes MellitusJournal of Clinical Investigation, 1982
- Profiles of metabolic control in diabetic children — Frequency of asymptomatic nocturnal hypoglycemiaMetabolism, 1981
- IN SEARCH OF THE SOMOGYI EFFECTThe Lancet, 1980
- Interaction of Endogenous Growth Hormone, Cortisol, and Catecholamines with Blood Glucose in Children with Brittle Diabetes MellitusPediatric Research, 1975
- Growth Hormone and Glucose Interrelationships in Diabetes: Studies of Inadvertent Hypoglycemic Episodes During Continuous Blood Glucose AnalysisJournal of Clinical Endocrinology & Metabolism, 1971
- Insulin-induced posthypoglycemic hyperglycemia as a cause of “brittle” diabetes: Clinical clues and therapeutic implicationsThe American Journal of Medicine, 1969
- Exacerbation of diabetes by excess insulin actionThe American Journal of Medicine, 1959